Unique ID issued by UMIN | UMIN000030732 |
---|---|
Receipt number | R000035094 |
Scientific Title | Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting Stent Trial: Extended Follow-up Study |
Date of disclosure of the study information | 2018/02/02 |
Last modified on | 2018/01/09 13:26:04 |
Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting Stent Trial:
Extended Follow-up Study
RESET:Extended Follow-up Study
Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting Stent Trial:
Extended Follow-up Study
RESET:Extended Follow-up Study
Japan |
Coronary Artery Disease
Cardiology |
Others
NO
To evaluate the long-term efficacy and safety of cobalt chrome everolimus-eluting stent (CoCr-EES) of XIENCE V and 1st generation sirolimus-eluting stent (SES) of Cypher
Safety
Any TLR
A composite of all-cause death and MI
Observational
Not applicable |
Not applicable |
Male and Female
3196 patients who participated in the RESET trial.
Patients who refuse to participate.
3196
1st name | |
Middle name | |
Last name | Takeshi Kimura |
Kyoto University Graduate School of Medicine
Department of Cardiovascular Medicine
54, Kawahara-cho, Shogoin, Sakyo-ku, Kyoto
075-751-4255
taketaka@kuhp.kyoto-u.ac.jp
1st name | |
Middle name | |
Last name | Hiroki Shiomi |
Kyoto University Graduate School of Medicine
Department of Cardiovascular Medicine
54, Kawahara-cho, Shogoin, Sakyo-ku, Kyoto
075-751-4255
hishiomi@kuhp.kyoto-u.ac.jp
Research Institute for Production Development
Abbott Vascular
Profit organization
NO
2018 | Year | 02 | Month | 02 | Day |
Unpublished
Preinitiation
2017 | Year | 12 | Month | 05 | Day |
2018 | Year | 01 | Month | 10 | Day |
This study is the extended follow-up study of the RESET randomized study.
2018 | Year | 01 | Month | 09 | Day |
2018 | Year | 01 | Month | 09 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035094